Evidence map›Paper›PMID 24337477›Full record

ArticleScience translational medicine2013

Stewardship practices of U.S. biobanks.

Gail E Henderson, Teresa P Edwards, R Jean Cadigan, Arlene M Davis, Catherine Zimmer, Ian Conlon, Bryan J Weiner

Abstract read
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Grudging Trust and the Limits of Trustworthy Biorepository Curation.The American journal of bioethics : AJOB · 2018
    Article
  6. Article
  7. Informed Consent in Translational Genomics: Insufficient Without Trustworthy Governance.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2018
    Article
  8. Assessing Researcher Needs for a Virtual Biobank.Biopreservation and biobanking · 2017
    Article
  9. Article
  10. "Forward-Thinking" in U.S. Biobanking.Genetic testing and molecular biomarkers · 2017
    Article
  11. Article
  12. Lessons from HeLa Cells: The Ethics and Policy of Biospecimens.Annual review of genomics and human genetics · 2016
    Review
  13. Article
  14. With great (participant) rights comes great (researcher) responsibility.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  15. Review
  16. The translational potential of research on the ethical, legal, and social implications of genomics.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Review
  17. Returning a Research Participant's Genomic Results to Relatives: Perspectives from Managers of Two Distinct Research Biobanks.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2015
    Article
  18. Article
  19. Underutilization of specimens in biobanks: an ethical as well as a practical concern?Genetics in medicine : official journal of the American College of Medical Genetics · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gail E HendersonDepartment of Social Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Teresa P Edwards
R Jean Cadigan
Arlene M Davis
Catherine Zimmer
Ian Conlon
Bryan J Weiner

Funding

UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
Center for Genomics and SocietyP50HG004488 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HENDERSON, GAIL E · 2007 to 2017
$12.6M
From Specimen to Biobank: Using an Organizational Perspective to Study ELSI IssueR01HG005227 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HENDERSON, GAIL E · 2010 to 2010
$603k
NCRR NIH HHS 5UL1RR025747-04S1NCRR NIH HHS U54RR024382-01A1NCRR NIH HHS UL1 RR025747NHGRI NIH HHS 1R01HG005227-01A1NHGRI NIH HHS P50 HG004488NHGRI NIH HHS R01 HG005227
6 · The paper itself

Abstract

Biobanks require new governance models that address their ethical and regulatory challenges. One model relies on stewardship of specimens throughout their life course. Here, we discuss findings from our survey of 456 U.S. biobank managers that addressed whether and how biobanks steward their specimens. The findings reveal that most biobanks do not create ongoing relationships with contributors but do practice stewardship over storing and sharing of specimens. Biobanks now need guidance to fully articulate stewardship practices that ensure respect for contributors while facilitating research.

Indexed as

Biological Specimen BanksBiomedical ResearchEthics, ResearchHumansResearcher-Subject RelationsSpecimen HandlingUnited States

Identifiers

PMID24337477
PMCPMC4185188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.